Stanley Laman Group Ltd. Buys 27,511 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Stanley Laman Group Ltd. grew its position in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 17.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 186,980 shares of the company's stock after purchasing an additional 27,511 shares during the period. Stanley Laman Group Ltd. owned about 0.26% of Schrödinger worth $3,691,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Nikko Asset Management Americas Inc. increased its stake in shares of Schrödinger by 108.7% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 2,464,911 shares of the company's stock worth $47,499,000 after purchasing an additional 1,283,949 shares during the period. Massachusetts Financial Services Co. MA increased its position in Schrödinger by 17.2% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,279,313 shares of the company's stock worth $43,968,000 after buying an additional 334,131 shares during the period. Millennium Management LLC lifted its holdings in shares of Schrödinger by 42.3% during the fourth quarter. Millennium Management LLC now owns 761,653 shares of the company's stock worth $14,692,000 after buying an additional 226,536 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Schrödinger by 4,213.0% during the first quarter. GAMMA Investing LLC now owns 120,592 shares of the company's stock worth $2,380,000 after buying an additional 117,796 shares during the last quarter. Finally, Two Sigma Investments LP bought a new stake in shares of Schrödinger in the fourth quarter valued at approximately $1,939,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Schrödinger

In related news, insider Karen Akinsanya sold 16,723 shares of the firm's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total transaction of $419,580.07. Following the completion of the sale, the insider now directly owns 15,625 shares of the company's stock, valued at $392,031.25. This trade represents a 51.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 8.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

SDGR has been the subject of several research analyst reports. KeyCorp upped their target price on shares of Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. Piper Sandler reduced their target price on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Schrödinger has a consensus rating of "Buy" and an average price target of $32.80.

Schrödinger Stock Down 1.1%

SDGR traded down $0.23 during midday trading on Monday, reaching $21.20. 1,352,713 shares of the company's stock were exchanged, compared to its average volume of 1,153,139. The business has a 50-day simple moving average of $23.64 and a two-hundred day simple moving average of $22.41. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of -9.06 and a beta of 1.63. Schrödinger, Inc. has a one year low of $16.60 and a one year high of $28.47.

Schrödinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $59.55 million for the quarter, compared to analyst estimates of $54.60 million. During the same quarter in the prior year, the company earned ($0.86) earnings per share. The business's revenue was up 62.7% compared to the same quarter last year. As a group, research analysts anticipate that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.